AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access | Just Accepted

Cholesterol metabolite 27-hydroxycholesterol promotes esophageal cancer cell migration by activating β‑catenin signaling

Kailin Jiao1,*Mengting Wang2,*Jie Wang3,*XinYa Wen4Zhong Li2 ( )Nan Wang5( )

1 Department of Nutrition, Tangdu Hospital, Fourth Military Medical University, Xi'an, China

2 The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China

3 Department of Clinical Nutrition, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China

4 Department of Integrative Medicine, Shaanxi University of Chinese Medicine, Xianyang, China

5 Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China

* These authors contributed equally to this work.

 

Show Author Information

Abstract

Objective: Esophageal cancer (EC) is an aggressive malignancy associated with a high mortality rate, and metastasis is one of the main causes of death in patients with EC. High cholesterol is positively associated with the risk of developing EC. 27-Hydroxycholesterol (27-HC) is the most abundant cholesterol metabolite. Here, we investigated the role of cholesterol and 27-HC in EC cell migration. Methods: The effects of cholesterol and 27-HC on EC cell migration were examined using migration assays in the human esophageal squamous cell line ECA109 and the human esophageal adenocarcinoma cell line OE33. Transient transfection and western blot analysis were performed to examine the mechanisms underlying the modulation of EC cell migration by glycogen synthase kinase-3-beta (GSK‑3β)/β‑catenin signaling. Results: Cholesterol induced epithelial-to-mesenchymal transition (EMT) and promoted the migration of EC cells. The enzyme CYP27A1, which catalyzes the conversion of cholesterol to 27-HC, promoted EC cell EMT and migration. 27-HC increased the production of reactive oxygen species (ROS), which promoted the phosphorylation and activation of the AKT and p38 signaling pathways. Phosphorylated AKT inhibited GSK-3β/β-catenin binding, which increased the free β-catenin level and its nuclear translocation. This process together with the activation of p-p38-related pathways promoted EMT and increased the migratory ability of EC cells. Conclusions: ROS production induced by cholesterol and its metabolite 27-HC activated the AKT signaling pathway and promoted the translocation of β-catenin into the nucleus, which induced EMT and increased the migration of EC cells. The p38 kinase induced the migration of EC cells through a mechanism other than β-catenin signaling. 

Electronic Supplementary Material

Download File(s)
2025-00212R2_materials.docx (17.2 KB)
2025-00212R2_figures.docx (396.3 KB)

References

【1】
【1】
 
 
Food Science and Human Wellness

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Jiao K, Wang M, Wang J, et al. Cholesterol metabolite 27-hydroxycholesterol promotes esophageal cancer cell migration by activating β‑catenin signaling. Food Science and Human Wellness, 2025, https://doi.org/10.26599/FSHW.2025.9250808

485

Views

31

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 05 February 2025
Revised: 25 March 2025
Accepted: 12 August 2025
Available online: 05 November 2025

© 2025 Beijing Academy of Food Sciences. Publishing services by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).